Macri, C., Dumont, C., Johnston, A. P. & Mintern, J. D. Targeting dendritic cells: a promising strategy to improve vaccine effectiveness. Clin. Transl. Immunol. 5, e66 (2016).

Article  Google Scholar 

Macri, C., Jenika, D., Ouslinis, C. & Mintern, J. D. Targeting dendritic cells to advance cross-presentation and vaccination outcomes. Semin. Immunol. 68, 101762 (2023).

Article  CAS  PubMed  Google Scholar 

Schetters, S. T. T. et al. Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity. Front. Immunol. 9, 990 (2018).

Article  PubMed  PubMed Central  Google Scholar 

Pooley, J. L., Heath, W. R. & Shortman, K. Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J. Immunol. 166, 5327–5330 (2001).

Article  CAS  PubMed  Google Scholar 

den Haan, J. M., Lehar, S. M. & Bevan, M. J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685–1696 (2000).

Article  Google Scholar 

Lahoud, M. H. et al. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc. Natl. Acad. Sci. USA. 109, 16270–16275 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang, J. G. et al. The dendritic cell receptor Clec9A binds damaged cells via exposed actin filaments. Immunity 36, 646–657 (2012).

Article  CAS  PubMed  Google Scholar 

Sancho, D. et al. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458, 899–903 (2009).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zelenay, S. et al. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J. Clin. Invest. 122, 1615–1627 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonifaz, L. et al. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196, 1627–1638 (2002).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bonifaz, L. C. et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199, 815–824 (2004).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caminschi, I. et al. The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement. Blood 112, 3264–3273 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lahoud, M. H. et al. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J. Immunol. 187, 842–850 (2011).

Article  CAS  PubMed  Google Scholar 

Dudziak, D. et al. Differential antigen processing by dendritic cell subsets in vivo. Science 315, 107–111 (2007).

Article  CAS  PubMed  Google Scholar 

Liu, Z., Zhou, H., Wang, W., Fu, Y. X. & Zhu, M. A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice. Oncoimmunology 5, e1147641 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Silva, M. O. et al. Antigen Delivery to DEC205(+) Dendritic Cells Induces Immunological Memory and Protective Therapeutic Effects against HPV-Associated Tumors at Different Anatomical Sites. Int. J. Biol. Sci. 17, 2944–2956 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sancho, D. et al. Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin. J. Clin. Invest. 118, 2098–2110 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kato, Y. et al. Targeting Antigen to Clec9A Primes Follicular Th Cell Memory Responses Capable of Robust Recall. J. Immunol. 195, 1006–1014 (2015).

Article  CAS  PubMed  Google Scholar 

Sulczewski, F. B. et al. Conventional type 1 dendritic cells induce TH 1, TH 1-like follicular helper T cells and regulatory T cells after antigen boost via DEC205 receptor. Eur. J. Immunol. 50, 1895–1911 (2020).

Article  CAS  PubMed  Google Scholar 

Sulczewski, F. B. et al. STAT6 signaling pathway controls germinal center responses promoted after antigen targeting to conventional type 2 dendritic cells. Curr. Res. Immunol. 2, 120–131 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhodapkar, M. V. et al. Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205. Sci. Transl. Med. 6, 232ra251 (2014).

Article  Google Scholar 

Griffiths, E. A. et al. NY-ESO-1 Vaccination in Combination with Decitabine Induces Antigen-Specific T-lymphocyte Responses in Patients with Myelodysplastic Syndrome. Clin. Cancer Res. 24, 1019–1029 (2018).

Article  CAS  PubMed  Google Scholar 

Morse, M. A. et al. Phase I study utilizing a novel antigen-presenting cell-targeted vaccine with Toll-like receptor stimulation to induce immunity to self-antigens in cancer patients. Clin. Cancer Res. 17, 4844–4853 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burmeister, W. P., Gastinel, L. N., Simister, N. E., Blum, M. L. & Bjorkman, P. J. Crystal structure at 2.2 A resolution of the MHC-related neonatal Fc receptor. Nature 372, 336–343 (1994).

Article  CAS  PubMed  Google Scholar 

Chaudhury, C. et al. The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan. J. Exp. Med. 197, 315–322 (2003).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raghavan, M., Bonagura, V. R., Morrison, S. L. & Bjorkman, P. J. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry 34, 14649–14657 (1995).

Article  CAS  PubMed  Google Scholar 

Roopenian, D. C. et al. The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J. Immunol. 170, 3528–3533 (2003).

Article  CAS  PubMed  Google Scholar 

Firan, M. et al. The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. Int. Immunol. 13, 993–1002 (2001).

Article  CAS  PubMed  Google Scholar 

Simister, N. E. & Rees, A. R. Isolation and characterization of an Fc receptor from neonatal rat small intestine. Eur J Immunol 15, 733–738 (1985).

Article  CAS  PubMed  Google Scholar 

Baker, K. et al. Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells. Proc. Natl. Acad. Sci. USA. 108, 9927–9932 (2011).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baker, K. et al. Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer. Immunity 39, 1095–1107 (2013).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qiao, S. W. et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proc. Natl. Acad. Sci. USA. 105, 9337–9342 (2008).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luber, C. A. et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 32, 279–289 (2010).

Article  CAS  PubMed  Google Scholar 

Edwards, A. D. et al. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 alpha+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33, 827–833 (2003).

Article  CAS  PubMed  Google Scholar 

Macri, C., Fancke, B., Radford, K. J. & O’Keeffe, M. Monitoring Dendritic Cell Activation and Maturation. Methods Mol. Biol. 1988, 403–418 (2019).

Article  CAS  PubMed  Google Scholar 

Wilson, K. R. et al. MHC Class II Ubiquitination Regulates Dendritic Cell Function and Immunity. J. Immunol. 207, 2255–2264 (2021).

Article  CAS  PubMed